-
Caribou Biosciences to Participate in Upcoming Investor Conferences
-
Citi Opens Positive Catalyst Watch on Caribou Biosciences Inc. (CRBU)
-
Caribou Biosciences to Participate in Upcoming Investor Conferences
-
Caribou Biosciences to Participate in Upcoming Investor Conferences
-
Caribou Biosciences to Participate in Upcoming Investor Conferences
-
Caribou Biosciences Reports Second Quarter 2022 Financial Results and Provides Business Update
-
Caribou Biosciences Inc. (CRBU) PT Raised to Street High $39 at Citi
-
UPDATE: Citi Upgrades Caribou Biosciences Inc. (CRBU) to Buy
-
Caribou Biosciences to Participate in Citi’s 16Th Annual BioPharma Virtual Conference
-
Caribou Biosciences Announces Closing of Upsized Initial Public Offering
-
Caribou Biosciences (CRBU) IPO Opens 10% Higher
-
Caribou Bioscience, Inc (CRBU) Prices Upsized 19M Share IPO at $16/sh
-
Caribou Biosciences Announces Pricing of Upsized Initial Public Offering
-
Caribou Biosciences, Inc (CRBU) Files up to $100M IPO

